by David Kent | Apr 30, 2020
Blood stem cells are the fundamental component of regenerative medicine applications involving the blood and immune system. Despite significant efforts and investment, the research community has largely failed to maintain fully functional blood stem cells for...
by Tara Fernandez | Feb 20, 2020
Immunotherapies have been heralded as a revolutionary paradigm shift in how cancer is treated, thanks to the exceptional cancer-killing properties of checkpoint inhibitors and chimeric antigen receptor (CAR) T cells. Today, approved therapies Yescarta™ and Kymriah™,...
by Sara M. Nolte | Feb 14, 2020
We’ve spent a lot of time swooning over CAR T-cells and CRISPR here at Signals, but recently a potential up-and-coming leading lady in the gene and cancer therapy fields has caught our eye. Our interest was piqued by a recent press release from The Max Delbruck Center...
by Lisa Willemse | Jan 9, 2020
It’s no secret that biology is unpredictable, random and sometimes messy. This is precisely what gives living organisms their singularity and uncanny ability to adapt. But as important as these traits might be in a herd of elephants as they adapt to climate change or...
by Farah Qaiser | Oct 30, 2019
Earlier this month, over 8,900 individuals (including me!) headed to Houston to attend the 2019 American Society of Human Genetics’ (ASHG) Annual Meeting and learn more about cutting-edge research, science literacy and policy issues in the fields of genetics and...
Comments